Lung Cancers Completed Phase 2 Trials for Pemetrexed (DB00642)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00234052Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTreatment
NCT01116219Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).Treatment
NCT01263782BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung CancerTreatment
NCT00407550Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT01443078Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)Treatment
NCT00111839Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung CancerTreatment
NCT00301808Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung CancerTreatment
NCT01344824Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never SmokersTreatment
NCT00798603Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00807573Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response AssessmentTreatment
NCT00745875ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer StudyTreatment
NCT007719530822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung CancerTreatment
NCT00744900Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)Treatment
NCT00660816Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00538681Study for Patients With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + PlaceboTreatment
NCT00577707Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)Treatment
NCT00456261First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLCTreatment
NCT00508144Single Agent Alimta in Poor Performance Status in Non-small Cell Lung CancerTreatment
NCT00268489Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT01588704Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung AdenocarcinomaTreatment
NCT01565538Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung AdenocarcinomaTreatment
NCT00193414Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00227565Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00227539Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerTreatment
NCT00117962Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung CancerTreatment
NCT00022646Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerTreatment
NCT00454194Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00226577Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.Treatment